Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: A systematic review and meta-analysis

European Journal of Cancer

Volumn 49, Issue 10, 2013, Pages 2365-2375

  Flohil, Sophie C ^a   Van Der Leest, Robert J T ^a   Arends, Lidia R ^a,b   De Vries, Esther ^a   Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Basal cell carcinoma; Epidemiology; Melanoma; Meta analysis; Risk; Second skin cancer; Skin cancer; Squamous cell carcinoma; Systematic review

Indexed keywords

AUSTRALIA; BASAL CELL CARCINOMA; CANCER PATIENT; CANCER RISK; EUROPE; HUMAN; KERATINOCYTE CARCINOMA; MELANOMA; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW;

EID: 84878380403     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.03.010     Document Type: Article

References (76)

1. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall A systematic review of worldwide incidence of non-melanoma skin cancer Br J Dermatol 166 5 2012 1069 1080
2. I. Marcil, and R.S. Stern Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis Arch Dermatol 136 12 2000 1524 1530
3. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
4. S. Ramachandran, A.A. Fryer, and A.G. Smith Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype Pharmacogenetics 11 3 2001 247 254
5. S. Ramachandran, R. Rajaratnam, A.G. Smith, J.T. Lear, and R.C. Strange Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma J Am Acad Dermatol 61 2 2009 247 251
6. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. [accessed May 6th 2011].
7. K. Aung, and T. Htay Thiazide diuretics and the risk of hip fracture Cochrane Database Syst Rev 10 2011 CD005185
8. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
9. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560
10. H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: multivariate approach and meta-regression Stat Med 21 4 2002 589 624
11. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 1997 629 634
12. P. Troyanova, S. Danon, and T. Ivanova Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria Neoplasma 49 2 2002 81 85
13. D. Kemmett, and C. Chan Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of squamous cell carcinoma Br J Dermatol 151 2004 30 31
14. A. Pulido, J.M. Bellon, and F. Carretero Epidemiological trends in non melanoma skin cancer in a Mediterranean population Melanoma Res 20 2010 e69 e70
15. A. Marghoob, A.W. Kopf, and R.S. Bart Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma J Am Acad Dermatol 28 1 1993 22 28
16. N.M. Richmond-Sinclair, N. Pandeya, and G.M. Williams Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study Int J Cancer 127 11 2010 2622 2629
17. M.M. Schreiber, T.E. Moon, S.H. Fox, and J. Davidson The risk of developing subsequent nonmelanoma skin cancers J Am Acad Dermatol 23 6 Pt 1 1990 1114 1118
18. T.Y. Chuang, A. Popescu, W.P. Su, and C.G. Chute Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota J Am Acad Dermatol 22 3 1990 413 417
19. G.D. Friedman, and I.S. Tekawa Association of basal cell skin cancers with other cancers (United States) Cancer Causes Control 11 10 2000 891 897
20. Z. Nugent, A.A. Demers, M.C. Wiseman, C. Mihalcioiu, and E.V. Kliewer Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer Cancer Epidemiol Biomarkers Prev 14 11 Pt 1 2005 2584 2590
21. N.H. Cox Basal cell carcinoma in young adults Br J Dermatol 127 1 1992 26 29
22. V. Kiiski, E. de Vries, and S.C. Flohil Risk factors for single and multiple basal cell carcinomas Arch Dermatol 146 8 2010 848 855
23. N.M. Mc Loone, J. Tolland, M. Walsh, and O.M. Dolan Follow-up of basal cell carcinomas: an audit of current practice J Eur Acad Dermatol Venereol 20 6 2006 698 701
24. T.Y. Chuang, N.A. Popescu, W.P. Su, and C.G. Chute Squamous cell carcinoma. A population-based incidence study in Rochester, Minn Arch Dermatol 126 2 1990 185 188
25. J.T. Efird, G.D. Friedman, L. Habel, I.S. Tekawa, and L.M. Nelson Risk of subsequent cancer following invasive or in situ squamous cell skin cancer Ann Epidemiol 12 7 2002 469 475
26. D. Czarnecki, T. Sutton, C. Czarnecki, and G. Culjak A 10-year prospective study of patients with skin cancer J Cutan Med Surg 6 5 2002 427 429
27. B.A. Raasch, and P.G. Buettner Multiple nonmelanoma skin cancer in an exposed Australian population Int J Dermatol 41 10 2002 652 658
28. M.R. Karagas, T.A. Stukel, and E.R. Greenberg Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group JAMA 267 24 1992 3305 3310
29. J. Graells The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population J Eur Acad Dermatol Venereol 18 2 2004 142 147
30. D.F. Gudbjartsson, P. Sulem, and S.N. Stacey ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma Nat Genet 40 7 2008 886 891
31. S.N. Stacey, D.F. Gudbjartsson, and P. Sulem Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits Nat Genet 40 11 2008 1313 1318
32. G. Tessari, L. Naldi, and L. Boschiero Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study Arch Dermatol 146 3 2010 294 299
33. P. Jensen, S. Hansen, and B. Moller Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens J Am Acad Dermatol 40 2 Pt 1 1999 177 186
34. R.S. Stern The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study J Am Acad Dermatol 66 4 2012 553 562
35. G.B. Jemec, and E.A. Holm Nonmelanoma skin cancer in organ transplant patients Transplantation 75 3 2003 253 257
36. T.C. Watt, P.D. Inskip, and K. Stratton Radiation-related risk of Basal cell carcinoma: a report from the childhood cancer survivor study J Natl Cancer Inst 104 16 2012 1240 1250
37. L. Wheless, J. Black, and A.J. Alberg Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review Cancer Epidemiol Biomarkers Prev 19 7 2010 1686 1695
38. S. Gandini, F. Sera, and M.S. Cattaruzza Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure Eur J Cancer 41 1 2005 45 60
39. V. Madan, J.T. Lear, and R.M. Szeimies Non-melanoma skin cancer Lancet 375 9715 2010 673 685
40. M. Egger, G.D. Smith, and J.A. Sterne Uses and abuses of meta-analysis Clin Med 1 6 2001 478 484
41. United States Preventative Services Task Force. Available from: http://archive.ahrq.gov/clinic/ajpmsuppl/skcarr.htm. [accessed August 2012].
42. C. Holterhues, L.V. van de Poll-Franse, E. de Vries, H.A. Neumann, and T.E. Nijsten Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population J Eur Acad Dermatol Venereol 26 11 2012 1389 1395
43. S.C. Flohil, E. de Vries, H.A. Neumann, J.W. Coebergh, and T. Nijsten Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands Acta Derm Venereol 91 1 2011 24 30
44. S.C. Flohil, C.M. Proby, and A.D. Forrest Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions Br J Dermatol 167 2 2012 22 28
45. S.C. Flohil, S. van Tiel, and S. Koljenovic Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice J Eur Acad Dermatol Venereol 2012 10.1111/j.1468-3083.2011.04407.x [Epub ahead of print]
46. P. Boyle, and D.M. Parkin Chapter 11 statistical methods for registries Cancer registration: principles and methods (IARC Scientific Publication no 95) 1991 International Agency for Research on Cancer Lyone, France 126 158
47. E. de Vries, R. Micallef, and D.H. Brewster Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions Arch Dermatol 148 3 2012 347 354
48. I. Ahmed, A.J. Sutton, and R.D. Riley Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey BMJ 344 2012 d7762
49. F. Levi, L. Randimbison, M. Maspoli, V.C. Te, and C. La Vecchia High incidence of second basal cell skin cancers Int J Cancer 119 6 2006 1505 1507
50. C.A. van Iersel, H.V. van de Velden, and C.D. Kusters Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up Br J Dermatol 153 5 2005 1078 1080
51. S.C. Flohil, S. Koljenovic, and E.R. de Haas Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands Br J Dermatol 165 4 2011 874 881
52. J.T. Lear, A.G. Smith, and A.H. Heagerty Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma Carcinogenesis 18 8 1997 1499 1503
53. F. Levi, L. Randimbison, C. La Vecchia, G. Erler, and V.C. Te Incidence of invasive cancers following squamous cell skin cancer Am J Epidemiol 146 9 1997 734 739
54. C. Yoong, and B. De'Ambrosis Cutaneous invasive squamous cell carcinoma: 10-year experience and recommendations for follow up Australas J Dermatol 50 4 2009 261 265
55. D.H. Frankel, B.H. Hanusa, and J.A. Zitelli New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up J Am Acad Dermatol 26 5 Pt 1 1992 720 726
56. L. Biro, E. Price, and P. MacWilliams Basal-cell carcinoma in office practice N Y State J Med 75 9 1975 1427 1433
57. A. Di Landro, E. Zaccaria, and L. Naldi Risk of developing a new basal cell carcinoma or other skin neoplasms in patients already treated for a basal cell carcinoma G Ital Dermatol Venereol 139 6 2004 507 514
58. G.T. Reizner, T.Y. Chuang, D.J. Elpern, J.L. Stone, and E.R. Farmer Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States J Am Acad Dermatol 29 2 Pt 1 1993 184 189
59. F. Revenga, J.F. Paricio, M.M. Vasquez, and V. del Villar Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma [5] J Eur Acad Dermatol Venereol 18 4 2004 514 515
60. M.M. Cantwell, L.J. Murray, and D. Catney Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland Br J Cancer 100 1 2009 174 177
61. F. Levi, C. La Vecchia, V.C. Te, L. Randimbison, and G. Erler Incidence of invasive cancers following basal cell skin cancer Am J Epidemiol 147 8 1998 722 726
62. C.P. Bower, J.T. Lear, and S. Bygrave Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England J Am Acad Dermatol 42 6 2000 988 991
63. M. Frisch, H. Hjalgrim, J.H. Olsen, and M. Melbye Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study Ann Intern Med 125 10 1996 815 821
64. B. Lindelof, B. Sigurgeirsson, P. Wallberg, and G. Eklund Occurrence of other malignancies in 1973 patients with basal cell carcinoma J Am Acad Dermatol 25 2 Pt 1 1991 245 248
65. T. Milan, E. Pukkala, and P.K. Verkasalo Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995 Int J Cancer 87 2 2000 283 288
66. T.Y. Chuang, G.T. Reizner, D.J. Elpern, J.L. Stone, and E.R. Farmer Squamous cell carcinoma in Kauai, Hawaii Int J Dermatol 34 6 1995 393 397
67. C. Dong, and K. Hemminki Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996 Int J Cancer 93 2 2001 155 161
68. M. Frisch, and M. Melbye New primary cancers after squamous cell skin cancer Am J Epidemiol 141 10 1995 916 922
69. S.K. Maitra, H. Gallo, C. Rowland-Payne, D. Robinson, and H. Moller Second primary cancers in patients with squamous cell carcinoma of the skin Br J Cancer 92 3 2005 570 571
70. C. Wassberg, M. Thorn, J. Yuen, T. Hakulinen, and U. Ringborg Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ Int J Cancer 83 3 1999 314 317
71. M. Schinstine, and G.D. Goldman Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery J Am Acad Dermatol 44 3 2001 497 499
72. K. Veien, and N.K. Veien Risk of developing subsequent nonmelanoma skin cancers Arch Dermatol 137 9 2001 1251
73. Karahalios E. Second primary cancers in Victoria. Second primary cancers in Victoria Victorian Cancer Registry. 2009.
74. C. Garbe, A. Paul, and H. Kohler-Spath Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 3 2003 520 529
75. R.J.T. van der Leest, L. Liu, and J.W.W. Coebergh Risk of second primary in situ and invasive melanoma in Dutch population-based cohort: 1989-2008 Br J Dermatol 167 6 2012 1321 1330
76. A. Pring, J. Verne, and D.A.R. de Berker The incidence of second primary skin cancer in an English region Br J Dermatol 163 2010 7